Table 6.
Variable | B | SE | Beta | p Value |
---|---|---|---|---|
Body weight (kg) | 0.023 | 0.014 | 0.073 | 0.105 |
Body fat (%) | 0.015 | 0.013 | 0.065 | 0.260 |
Waist circumference (cm) | 0.015 | 0.017 | 0.042 | 0.382 |
Systolic BP (mm Hg) | −0.035 | 0.030 | −0.050 | 0.247 |
Diastolic BP (mm Hg) | −0.035 | 0.020 | −0.079 | 0.081 |
Total cholesterol (mmol/L) | 0.001 | 0.002 | 0.021 | 0.596 |
HDL cholesterol (mmol/L) | 0.000 | 0.001 | −0.005 | 0.908 |
LDL cholesterol (mmol/L) | 0.001 | 0.001 | 0.026 | 0.512 |
Triglycerides (mmol/L) | 0.000 | 0.001 | −0.001 | 0.980 |
Fasting glucose (mmol/L) | 0.001 | 0.001 | 0.029 | 0.507 |
Fasting insulin (mIU/L) | 0.064 | 0.019 | 0.178 | 0.001 * |
HOMA-IR | 0.017 | 0.006 | 0.138 | 0.006 * |
Matsuda index | −0.010 | 0.008 | −0.057 | 0.207 |
CRP (mg/L) | −0.007 | 0.006 | −0.059 | 0.201 |
Adiponectin (mg/L) | 0.012 | 0.009 | 0.056 | 0.185 |
1 Regression models also included BMI at randomization, changes in the dependent variables during the weight loss phase, gender, type of centre, dietary protein intake (as % of energy intake), animal protein intake (as % of total protein intake), GI, dietary fat intake (as % of energy intake) and fibre intake (g/1000 kcal); * remains significant after adjusting for weight change during WM.